Chenchen Li

419 total citations
19 papers, 279 citations indexed

About

Chenchen Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chenchen Li has authored 19 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Chenchen Li's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Chenchen Li is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Chenchen Li collaborates with scholars based in China, United States and Sweden. Chenchen Li's co-authors include Xuan Pan, Siwen Liu, Jifeng Feng, Xiaoyou Li, Wei Zhao, Jiayuan Huang, Banzhou Pan, Jianwei Lu, Yujie Tan and Xiao-Xiao Dinglin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Chenchen Li

18 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenchen Li China 8 211 191 43 35 21 19 279
Suxia Luo China 11 225 1.1× 215 1.1× 20 0.5× 34 1.0× 15 0.7× 15 294
Weihai Ning China 10 145 0.7× 94 0.5× 43 1.0× 48 1.4× 24 1.1× 33 251
Bohai Feng Germany 8 203 1.0× 126 0.7× 53 1.2× 64 1.8× 12 0.6× 10 362
Jian Shi China 11 271 1.3× 257 1.3× 40 0.9× 45 1.3× 17 0.8× 25 376
Roya Shahbazi Iran 7 243 1.2× 201 1.1× 24 0.6× 40 1.1× 14 0.7× 10 321
Zheng Zhao China 8 250 1.2× 213 1.1× 86 2.0× 37 1.1× 13 0.6× 15 321
Xiujie Sheng China 9 216 1.0× 202 1.1× 55 1.3× 35 1.0× 14 0.7× 18 319
Xuqiang Zhu China 9 211 1.0× 169 0.9× 37 0.9× 30 0.9× 19 0.9× 15 306
Negin Taghehchian Iran 12 248 1.2× 174 0.9× 29 0.7× 54 1.5× 14 0.7× 33 320

Countries citing papers authored by Chenchen Li

Since Specialization
Citations

This map shows the geographic impact of Chenchen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenchen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenchen Li more than expected).

Fields of papers citing papers by Chenchen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenchen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenchen Li. The network helps show where Chenchen Li may publish in the future.

Co-authorship network of co-authors of Chenchen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chenchen Li. A scholar is included among the top collaborators of Chenchen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenchen Li. Chenchen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yang, Zhuo, Peng Ji, Wenfei Zhang, et al.. (2025). Danggui Buxue Decoction inhibits pulmonary fibrosis by alleviating TGF-β1-induced proliferation and apoptosis in EBL cells via PI3K/AKT/FOXO1 pathway. Journal of Ethnopharmacology. 353(Pt B). 120384–120384.
3.
Li, Chenchen, Xiaohui Sun, Gongshe Yang, et al.. (2024). Identification of different myofiber types in pigs muscles and construction of regulatory networks. BMC Genomics. 25(1). 400–400. 6 indexed citations
4.
Pan, Xuan, Chenchen Li, & Jifeng Feng. (2023). The role of LncRNAs in tumor immunotherapy. Cancer Cell International. 23(1). 30–30. 25 indexed citations
5.
Li, Chenchen, et al.. (2022). Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10. Journal of Oncology. 2022. 1–11. 1 indexed citations
6.
Liu, Siwen, Na Yin, Jie Ni, et al.. (2022). Associations between disrupted functional brain network topology and cognitive impairment in patients with rectal cancer during chemotherapy. Frontiers in Oncology. 12. 927771–927771. 1 indexed citations
7.
Liu, Siwen, Chenchen Li, Jie Ni, et al.. (2022). Topological Abnormalities of Pallido-Thalamo-Cortical Circuit in Functional Brain Network of Patients With Nonchemotherapy With Non-small Cell Lung Cancer. Frontiers in Neurology. 13. 821470–821470. 6 indexed citations
8.
Liu, Siwen, Jie Ni, Chenchen Li, et al.. (2022). Chemotherapy-induced functional brain abnormality in colorectal cancer patients: a resting‐state functional magnetic resonance imaging study. Frontiers in Oncology. 12. 900855–900855. 2 indexed citations
9.
Zhou, Xiaorong, Chenchen Li, Daniel Y. Li, et al.. (2021). Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients. Scientific Reports. 11(1). 7633–7633. 12 indexed citations
10.
Yang, Yutao, Yueting Li, Bo Liu, et al.. (2021). Involvement of Scratch2 in GalR1-mediated depression-like behaviors in the rat ventral periaqueductal gray. Proceedings of the National Academy of Sciences. 118(24). 5 indexed citations
11.
Li, Chenchen, Wei Zhao, Xuan Pan, et al.. (2020). LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1. Oncogene. 39(39). 6157–6171. 44 indexed citations
12.
Huang, Jiayuan, et al.. (2020). LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1. Cell Death and Disease. 11(7). 525–525. 46 indexed citations
13.
Zhou, Xiaorong, Chenchen Li, Zhao Zhang, et al.. (2020). Kinetics of Plasma cfDNA Predicts Clinical Response in Non-Small Cell Lung Cancer Patients. SSRN Electronic Journal. 1 indexed citations
14.
Bi, Zhuofei, Qingjian Li, Xiao-Xiao Dinglin, et al.. (2020). Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/β‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy. Advanced Science. 7(18). 2000915–2000915. 73 indexed citations
15.
Zhao, Wei, et al.. (2020). LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1. Frontiers in Cell and Developmental Biology. 8. 585251–585251. 33 indexed citations
16.
Zhao, Xia, Chenchen Li, Siwen Liu, et al.. (2019). Inhibitor of ghrelin receptor reverses gefitinib resistance in lung cancer. Human Cell. 32(3). 360–366. 5 indexed citations
18.
Li, Chenchen, Xia Zhao, Yang Yang, et al.. (2018). Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway. Medical Science Monitor. 24. 2750–2757. 7 indexed citations
19.
Li, Chenchen, Jian Wu, Zhuo Wang, & Jifeng Feng. (2014). [A comparison of direct sequencing and ARMS assay performance in EGFR mutation analysis of non-small cell lung cancer patients].. SHILAP Revista de lepidopterología. 17(8). 606–11. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026